GDF2 Antikörper (AA 351-429) (Cy3)
Kurzübersicht für GDF2 Antikörper (AA 351-429) (Cy3) (ABIN885270)
Target
Alle GDF2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 351-429
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Homologie
- Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human BMP9
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- GDF2 (Growth Differentiation Factor 2 (GDF2))
-
Andere Bezeichnung
- BMP9
-
Hintergrund
-
Synonyms: BMP9, HHT5, BMP-9, Growth/differentiation factor 2, GDF-2, Bone morphogenetic protein 9, GDF2
Background: Potent circulating inhibitor of angiogenesis. Could be involved in bone formation. Signals through the type I activin receptor ACVRL1 but not other Alks. Signaling through SMAD1 in endothelial cells requires TGF-beta coreceptor endoglin/ENG.
-
Gen-ID
- 2658
-
UniProt
- Q9UK05
-
Pathways
- Transition Metal Ion Homeostasis
Target
-